Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» clinical trials
clinical trials
Nasal Vaccine Starts Trial to Protect Against Alzheimer's
BioSpace
Tue, 11/16/21 - 10:31 pm
Alzheimer's disease
clinical trials
vaccines
I-Mab Biopharma
Jiangsu Nhwa Pharmaceutical
Molecular Partners' Covid-19 therapy proves inactiv
EP Vantage
Tue, 11/16/21 - 11:54 am
Molecular Partners
COVID-19
clinical trials
NIH
Apellis' eye med application on track for next year after FDA OKs inclusion of phase 2 data
Fierce Pharma
Mon, 11/15/21 - 11:51 pm
Apellis Pharmaceuticals
pegcetacoplan
FDA
clinical trials
age-related macular degeneration
PhaseBio Reversal Agent Continues to Show Promise in Phase III
BioSpace
Mon, 11/15/21 - 11:46 pm
PhaseBio
clinical trials
bentracimab
bloodthinner reversals
Moderna, AstraZeneca announce positive AZD8601 data from Phase 2 study in heart failure
Seeking Alpha
Mon, 11/15/21 - 12:27 pm
Moderna Therapeutics
MRNA
AstraZeneca
clinical trials
heart failure
Protagonist posts phase 2 hormone replacement data, pitching for lead role in genetic iron overload disease
Fierce Biotech
Mon, 11/15/21 - 10:59 am
Protagonist Therapeutics
clinical trials
J&J looks to toss its SGLT2 hat in the ring for two types of heart failure
Endpoints
Sun, 11/14/21 - 10:47 pm
JNJ
Invokana
heart failure
clinical trials
Cortexyme plans path forward for Alzheimer's drug that failed study
BioPharma Dive
Fri, 11/12/21 - 10:51 am
Cortexyme
Alzheimer's disease
clinical trials
With $100M, startup to bring Lilly-licensed drug into trials
Bizjournals
Thu, 11/11/21 - 11:05 am
Acrivon Therapeutics
Eli Lilly
clinical trials
Eisai-Biogen Alzheimer's Drug Shows Amyloid Reduction, Disease-Modifying Effect
BioSpace
Thu, 11/11/21 - 10:55 am
Eisai
Biogen
lecanemab
Alzheimer's disease
clinical trials
Immatics' cell therapy blasts solid tumors in phase 1, but durability spooks investors. Will dialing up the dose help?
Fierce Biotech
Wed, 11/10/21 - 10:45 am
Immatics
cell therapy
solid tumors
clinical trials
Largest psilocybin trial finds the psychedelic is effective in treating serious depression
Stat
Tue, 11/9/21 - 11:37 pm
psychedelic drugs
psilocybin
treatment-resistant depression
COMPASS Pathways
clinical trials
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Fierce Biotech
Tue, 11/9/21 - 10:49 am
Mirati Therapeutics
Amgen
KRAS
clinical trials
Merck
Keytruda
Regeneron COVID-19 antibody drug reduces infection risk 82% in clinical trial
Beckers Hospital Review
Mon, 11/8/21 - 11:03 am
Regeneron
COVID-19
antibodies
clinical trials
Propel fails to propel Nektar
EP Vantage
Mon, 11/8/21 - 10:48 am
Nektar Therapeutics
Merck
bempegaldesleukin
clinical trials
metastatic non-small cell lung cancer
Trial flop busts Deciphera’s blockbuster hopes for Qinlock
Pharmaforum
Sun, 11/7/21 - 10:57 pm
Deciphera Pharma
Qinlock
clinical trials
GIST
These Clinical Results Are Good News for AstraZeneca
Motley Fool
Sun, 11/7/21 - 10:52 pm
AstraZeneca
Imfinizi
biliary tract cancer
clinical trials
Moderna scraps lead mRNA chikungunya candidate after phase 1, slowing push beyond prophylactic vaccines
Fierce Biotech
Fri, 11/5/21 - 09:44 am
Moderna Therapeutics
vaccines
MRNA
chikungunya virus
clinical trials
Sangamo's Fabry gene therapy clears early clinical test, firing starting gun on preparations for phase 3
Fierce Biotech
Thu, 11/4/21 - 10:48 am
Sangamo Therapeutics
Fabry disease
gene therapy
clinical trials
ST-920
ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again
Fierce Biotech
Thu, 11/4/21 - 10:27 am
BeiGene
Brukinsa
leukemia
clinical trials
AbbVie
JNJ
Imbruvica
Pages
« first
‹ previous
…
74
75
76
77
78
79
80
81
82
…
next ›
last »